查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
罕见神经疾病治疗市场:各类药物，各疾病类型，各用途，各国，各地区:产业分析，市场规模，市场占有率，2023-2030年预测
市场调查报告书
商品编码
1320165

罕见神经疾病治疗市场:各类药物，各疾病类型，各用途，各国，各地区:产业分析，市场规模，市场占有率，2023-2030年预测

Rare Neurological Disease Treatment Market with COVID-19 Impact Analysis, By Drug Class, By Disease Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3个工作天内

价格

报告要点

罕见神经系统疾病治疗市场规模将于 2022 年达到 94.353 亿美元，2023 年至 2030 年复合年增长率为 7.7%

罕见神经疾病治疗市场 - 市场动态：

研发活动的增加预计将推动对罕见神经疾病治疗的需求。

研究人员、医疗专业人员、製药公司和患者权益团体之间的合作对于加速罕见神经系统疾病治疗方法的发现至关重要。患者权益组织透过促进、支持和提高研究意识来改善患者治疗结果和治疗选择。新一代定序、高通量筛选和基因编辑方法等技术的进步正在加速寻找和开发罕见神经系统疾病的可行治疗方法。透过这些技术，研究人员能够确定治疗标靶、开发全新药物并制定个人化治疗策略。

基因组学和分子生物学的进步使人们更了解罕见神经系统疾病所涉及的生物遗传学和分子生物学发展。这些资讯为精准医学和标靶治疗开启了新的可能性。

罕见神经疾病治疗市场 - 主要见解：

  • 据研究分析师分享的分析，全球罕见神经疾病治疗市场在预测期内（2023-2030 年）预计将以每年约 7.7% 的复合年增长率增长。
  • 由于对动物健康和营养的日益关注，罕见神经疾病治疗行业预计将大幅增长。
  • 按疾病类型划分，阿兹海默症预计将在 2022 年占最大的市场占有率。
  • 从应用来看，到 2030 年，医院药局领域预计将占主要市场占有率。
  • 按药物类别划分，抗忧郁药物区隔市场将在 2022 年占领先地位。
  • 依地区划分，北美成为 2022 年最大的收入来源。

罕见神经系统疾病治疗市场 - 区隔分析：

全球罕见神经疾病治疗市场依据药物类别、疾病类型、应用和区域进行区隔。

市场依药物类别分为五大类：抗忧郁药、抗精神病药、胆碱酯?抑制剂、生物製剂等。抗忧郁药物区隔市场占主导地位。用于治疗疾病的抗忧郁药物需求的不断增长推动了市场的成长。

市场依疾病类型分为四类：阿兹海默症、发作性睡病、硬化症等。阿兹海默症领域占市场主导地位。阿兹海默症的盛行率不断上升正在影响市场的成长。

市场依应用分为三类：医院和诊所、手术中心和其他。医院药房领域占市场主导地位。医院层级神经系统疾病治疗数量的增加推动了这一领域的成长。

罕见神经疾病治疗市场 - 地理洞察：

从地理来看，该市场遍布北美、拉丁美洲、欧洲、亚太地区和中东非洲地区。这些地区根据其开展业务的国家进一步划分。

罕见神经疾病治疗市场 - 竞争格局：

神经系统疾病的盛行率不断增加，影响着罕见的神经系统疾病治疗市场。公司使用多种销售管道来销售其解决方案和产品，例如公司网站和产品类型。产品在多种因素上竞争，包括技术、产品开发和行销。公司巩固其影响力和增加市场占有率的主要方法和策略包括新产品发布、研发支出、分销网络开发和併购。以下介绍一些最近的趋势。

最近动态

2021年，Biogen开发了小分子治疗性反义寡核?酸Spinraza（nusinersen）。

研究的主要特点

  • 本研究报告提供了罕见神经疾病治疗市场的市场规模、复合年增长率、估计和预测（2023-2030 年），并以 2022 年为基准年。
  • 这份研究报告为客户提供了有关罕见神经疾病治疗市场的最新趋势见解。
  • 该研究报告阐明了各个区隔市场/国家的潜在成长机会，并解释了罕见神经疾病治疗市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、现有公司面临的挑战以及维持罕见神经疾病治疗市场的成长因素
  • 研究范围详细讨论了罕见神经疾病治疗市场规模、预测、复合年增长率以及 COVID-19 对市场动态的影响。本报告也详细介绍了新冠疫情后罕见神经系统疾病治疗市场的详细见解。
  • 为了向本报告的使用者提供对罕见神经疾病治疗市场的全面了解，本报告也对罕见神经疾病治疗市场的竞争格局和主要创新者进行了分析。
  • 研究涵盖成长前景映射分析，根据市场规模、成长率和吸引力对所有产业领域进行基准测试。
  • 本报告提供了主要市场参与者的详细公司概况，以帮助了解在罕见神经疾病治疗市场运营的公司的财务状况和跨药物类别的战略举措。Masu。
  • 此外，该报告还揭示了全球和区域市场主要参与者的重要收购和併购、联盟和合资企业、新产品发布、研发以及区域扩张。
  • 《全球罕见神经疾病治疗市场报告》主要针对该行业的各个利益相关者，例如供应商、投资者、新进业者、分销商和财务分析师。

目录

第1章 罕见神经疾病治疗市场概要

  • 调查范围

第2章 摘要整理

  • 市场明细
  • 竞争考察

第3章 罕见神经疾病治疗主要的市场趋势

  • 罕见神经疾病治疗推动市场要素
  • 罕见神经疾病治疗阻碍市场要素
  • 罕见神经疾病治疗市场机会
  • 罕见神经疾病治疗市场今后趋势

第4章 罕见神经疾病治疗产业的调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法规结构的分析

第5章 罕见神经疾病治疗市场:COVID-19影响分析

  • COVID-19前的影响分析
  • COVID-19后的影响分析

第6章 罕见神经疾病治疗的市场形势

  • 罕见神经疾病治疗市场占有率分析，2022年
  • 各主要製造商的明细资料
    • 现有企业的分析
    • 新兴企业的分析

第7章 罕见神经疾病治疗市场- 各类药物

  • 概要
    • 各类药物的市场区隔占有率分析
    • 抗忧郁症药
    • 抗精神病药
    • 胆碱酯?抑制剂
    • 生技药品
    • 其他

第8章 罕见神经疾病治疗市场- 各疾病类型

  • 概要
    • 各疾病类型市场区隔占有率分析
    • 阿兹海默症
    • 猝睡症
    • 硬化症
    • 其他

第9章 罕见神经疾病治疗市场- 各用途

  • 概要
    • 各用途市场区隔占有率分析
    • 医院和诊疗所
    • 外科中心
    • 其他

第10章 罕见神经疾病治疗市场-各地区

  • 简介
  • 北美
    • 概要
    • 北美的罕见神经疾病治疗的主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概要
    • 欧洲的罕见神经疾病治疗的主要製造商
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区(APAC)
    • 概要
    • 亚太地区的罕见神经疾病治疗的主要製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 其他
  • 南美
    • 概要
    • 南美的罕见神经疾病治疗的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概要
    • 中东及非洲的罕见神经疾病治疗的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第11章 主要供应商分析- 罕见神经疾病治疗产业

  • 竞争仪表板
  • 企业简介
    • Biogen Inc.
    • Genzyme Corporation
    • Novartis International AG
    • Roche Holding AG
    • Pfizer Inc.
    • Johnson &Johnson
    • AbbVie Inc.
    • Merck &Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Alexion Pharmaceuticals, Inc.
    • Amgen Inc.
    • Vertex Pharmaceuticals Incorporated
    • Ionis Pharmaceuticals, Inc.
    • Sarepta Therapeutics, Inc.

第12章 分析师的全方位展望

Product Code: ANV1476

REPORT HIGHLIGHT

Rare Neurological Disease Treatment Market size was valued at USD 9,435.3 Million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

The treatment of rare neurological diseases varies depending on the specific condition and its underlying cause. Thus, it becomes essential to consult with a healthcare professional or specialist for treatment of these neurological diseases.

Rare Neurological Disease Treatment Market- Market Dynamics:

Increasing research and development activities is expected to propel the rare neurological disease treatment demand.

Collaboration among researchers, medical professionals, pharmaceutical firms, and patient advocacy organizations has been essential in promoting the creation of medicines for uncommon neurological illnesses. Patient advocacy groups promote research, help, and create awareness, which improves patient outcomes and treatment alternatives. Technology advancements like next-generation sequencing, high-throughput screening, and gene editing methods have sped up the search for and development of viable treatments for uncommon neurological illnesses. Researchers may now identify therapeutic targets, create brand-new medications, and personalize therapy strategies thanks to these technologies.

The biological genetic and molecular developments involved in uncommon neurological illnesses are now better understood because of developments in genomics and molecular biology. This information has created new possibilities for precision medicine and targeted therapeutics.

Rare Neurological Disease Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Rare Neurological Disease Treatment market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2023-2030)
  • The Rare Neurological Disease Treatment industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Disease Type, Alzheimer's disease segment was predicted to show maximum market share in the year 2022.
  • Based on Application, hospital pharmacies segment is expected to hold significant market share by 2030.
  • Based on Drug Class segmentation, anti-depressants segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Rare Neurological Disease Treatment Market- Segmentation Analysis:

The Global Rare Neurological Disease Treatment Market is segmented on the basis of Drug Class, Disease Type, Application, and Region.

The market is divided into five categories based on Drug Class: Anti-depressants, anti-psychotics, cholinesterase inhibitors, biologics, and others. The Anti-depressants segment dominates the market. Growing demand for anti-depressants for disease care is contributing to market growth.

The market is divided into four categories based on Disease Type: Alzheimer's disease, narcolepsy, sclerosis, and others. The Alzheimer's disease segment dominates the market. Growing prevalence of Alzheimer disorders which is influencing the market growth.

The market is divided into three categories based on Application: hospitals & clinics, surgical centers, and others. The hospitals pharmacies segment dominates the market. The rising number of neurological disease treatment at hospital level is increasing the segment growth.

Rare Neurological Disease Treatment Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rare Neurological Disease Treatment Market- Competitive Landscape:

Owing to the rising prevalence of neurological disorders, which influence the rare neurological disease treatment market. Several distribution channels, including corporate websites, and Disease Types, are used by businesses to sell their solutions & products. Products compete on various factors, such as technology, product creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and grow their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In 2021, Biogen developed Spinraza (nusinersen), an antisense oligonucleotide, for the treatment of small molecular therapies.

Key features of the study:

  • This proposed research study on Rare Neurological Disease Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Rare Neurological Disease Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Rare Neurological Disease Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Rare Neurological Disease Treatment market
  • Impact of COVID-19 on Rare Neurological Disease Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Rare Neurological Disease Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Rare Neurological Disease Treatment market, we have also included competitive landscape and key innovator analysis for the Rare Neurological Disease Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial in Drug Class and strategic initiatives of players operating in the Rare Neurological Disease Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Rare Neurological Disease Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET KEY PLAYERS

  • Biogen Inc.
  • Genzyme Corporation
  • Novartis International AG
  • Roche Holding AG
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • Vertex Pharmaceuticals Incorporated
  • Ionis Pharmaceuticals, Inc.
  • Sarepta Therapeutics, Inc.

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DRUG CLASS

  • Anti-depressants
  • Anti-psychotics
  • Cholinesterase inhibitors
  • Biologics
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Alzheimer's disease
  • Narcolepsy
  • Sclerosis
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY APPLICATION

  • Hospitals & clinics
  • Surgical centers
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rare Neurological Disease Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rare Neurological Disease Treatment Market Snippet by Drug Class
    • 2.1.2. Rare Neurological Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Rare Neurological Disease Treatment Market Snippet by Application
    • 2.1.4. Rare Neurological Disease Treatment Market Snippet by Country
    • 2.1.5. Rare Neurological Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Rare Neurological Disease Treatment Key Market Trends

  • 3.1. Rare Neurological Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rare Neurological Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rare Neurological Disease Treatment Market Opportunities
  • 3.4. Rare Neurological Disease Treatment Market Future Trends

4. Rare Neurological Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rare Neurological Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rare Neurological Disease Treatment Market Landscape

  • 6.1. Rare Neurological Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rare Neurological Disease Treatment Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Anti-depressants
    • 7.1.3. Anti-psychotics
    • 7.1.4. Cholinesterase inhibitors
    • 7.1.5. Biologics
    • 7.1.6. Others

8. Rare Neurological Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Alzheimer's disease
    • 8.1.3. Narcolepsy
    • 8.1.4. Sclerosis
    • 8.1.5. Others

9. Rare Neurological Disease Treatment Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 9.1.2. Hospital & clinics
    • 9.1.3. Surgical centers
    • 9.1.4. Others

10. Rare Neurological Disease Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Rare Neurological Disease Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Rare Neurological Disease Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Rare Neurological Disease Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Rare Neurological Disease Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Rare Neurological Disease Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Rare Neurological Disease Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biogen Inc.
    • 11.2.2. Genzyme Corporation
    • 11.2.3. Novartis International AG
    • 11.2.4. Roche Holding AG
    • 11.2.5. Pfizer Inc.
    • 11.2.6. Johnson & Johnson
    • 11.2.7. AbbVie Inc.
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Teva Pharmaceutical Industries Ltd.
    • 11.2.10. Takeda Pharmaceutical Company Limited
    • 11.2.11. Alexion Pharmaceuticals, Inc.
    • 11.2.12. Amgen Inc.
    • 11.2.13. Vertex Pharmaceuticals Incorporated
    • 11.2.14. Ionis Pharmaceuticals, Inc.
    • 11.2.15. Sarepta Therapeutics, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rare Neurological Disease Treatment Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Rare Neurological Disease Treatment Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Rare Neurological Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Rare Neurological Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Rare Neurological Disease Treatment Market: Regional snapshot (2022)
  • TABLE Rare Neurological Disease Treatment Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rare Neurological Disease Treatment Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rare Neurological Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)